|Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial|
BJ Monk, A Poveda, I Vergote, F Raspagliesi, K Fujiwara, DS Bae, ...
The lancet oncology 15 (8), 799-808, 2014
|Peripheral CD4+ CD8+ T cells are differentiated effector memory cells with antiviral functions|
M Nascimbeni, EC Shin, L Chiriboga, DE Kleiner, B Rehermann
Blood 104 (2), 478-486, 2004
|MHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cells|
P Leone, EC Shin, F Perosa, A Vacca, F Dammacco, V Racanelli
Journal of the National Cancer Institute 105 (16), 1172-1187, 2013
|Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ|
C Choi, JY Park, J Lee, JH Lim, EC Shin, YS Ahn, CH Kim, SJ Kim, ...
The Journal of Immunology 162 (4), 1889-1895, 1999
|Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection|
EC Shin, U Seifert, T Kato, CM Rice, SM Feinstone, PM Kloetzel, ...
The Journal of clinical investigation 116 (11), 3006-3014, 2006
|Foxp3+ CD4+ CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C|
T Manigold, EC Shin, E Mizukoshi, K Mihalik, KK Murthy, CM Rice, ...
Blood 107 (11), 4424-4432, 2006
|p16 is a major inactivation target in hepatocellular carcinoma|
MJ Baek, Z Piao, NG Kim, C Park, EC Shin, JH Park, HJ Jung, CG Kim, ...
Cancer 89 (1), 60-68, 2000
|Apoptosis in human hepatoma cell lines by chemotherapeutic drugs via Fas‐dependent and Fas‐independent pathways|
S Jiang, MJ Song, EC Shin, MO Lee, SJ Kim, JH Park
Hepatology 29 (1), 101-110, 1999
|Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension|
JC Youn, HT Yu, BJ Lim, MJ Koh, J Lee, DY Chang, YS Choi, SH Lee, ...
Hypertension 62 (1), 126-133, 2013
|Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays|
HO Kim, HS Kim, JC Youn, EC Shin, S Park
Journal of translational medicine 9 (1), 113, 2011
|IFN‐γinduces cell death in human hepatoma cells through a trail/death receptor‐mediated apoptotic pathway|
EC Shin, JM Ahn, CH Kim, Y Choi, YS Ahn, H Kim, SJ Kim, JH Park
International journal of cancer 93 (2), 262-268, 2001
|New advances in CMV and immunosenescence|
P Sansoni, R Vescovini, FF Fagnoni, A Akbar, R Arens, YL Chiu, ...
Experimental gerontology 55, 54-62, 2014
|Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatin|
EC Shin, YR Seong, CH Kim, H Kim, YS Ahn, K Kim, SJ Kim, SS Hong, ...
Experimental & molecular medicine 34 (2), 114, 2002
|Immune responses and immunopathology in acute and chronic viral hepatitis|
EC Shin, PS Sung, SH Park
Nature Reviews Immunology 16 (8), 509, 2016
|Expression of Fas ligand in human hepatoma cell lines: Role of hepatitis‐B virus X (HBX) in induction of Fas ligand|
EC Shin, JS Shin, JH Park, H Kim, SJ Kim
International journal of cancer 82 (4), 587-591, 1999
|Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection|
MO Lee, YH Choi, EC Shin, HJ Kang, YM Kim, SY Jeong, JK Seong, ...
Journal of hepatology 37 (3), 380-386, 2002
|Expression patterns of α-synuclein in human hematopoietic cells and in Drosophila at different developmental stages|
EC Shin, SE Cho, DK Lee, MW Hur, SR Paik, JH Park, J Kim
Molecules and cells 10 (1), 65-70, 2000
|Complete prevention of blood loss with self-sealing haemostatic needles|
M Shin, SG Park, BC Oh, K Kim, S Jo, MS Lee, SS Oh, SH Hong, EC Shin, ...
Nature materials 16 (1), 147, 2017
|Hepatitis C virus infection enhances TNFα‐induced cell death via suppression of NF‐κB|
J Park, W Kang, SW Ryu, WI Kim, DY Chang, DH Lee, DY Park, YH Choi, ...
Hepatology 56 (3), 831-840, 2012
|Expression of Fas-related genes in human hepatocellular carcinomas|
EC Shin, JS Shin, JH Park, JJ Kim, H Kim, SJ Kim
Cancer letters 134 (2), 155-162, 1998